CDMO Profile

Avid Bioservices

Avid Bioservices Contract Manufacturing & Development (CDMO) Profile



Avid Bioservices (NASDAQ: CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid’s services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization.

CDMO Services:
Biologics; Cell & Gene Therapy Drug Substance Manufacturing (API); Research & Development; Analytical Development

Year Founded: 2002

Head Office: Tustin, United States

Number of Facilities: 2

Facility locations: North America

Website: Visit the Avid Bioservices website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.